Drchrono vs NextGen: Which One in 2026?

Medical practices do not lose an EHR decision in the demo. They lose it six weeks later, when the front desk is still working two schedules, the biller is posting charges in the old system, and a partner asks why the conversion quote did not mention eligibility, e-prescribing identity proofing, or the week of dual charting.

TL;DR: Pick Drchrono if you run an independent clinic and you want scheduling, charting, and claims in one mobile cloud database. Pick NextGen if you run a specialty group that needs practice management, patient access, population health, and revenue cycle in one loop. Neither vendor publishes a 2026 list price, so the partner conversation is a written quote on seats, modules, and migration — not a number you saw on a blog.

How we evaluated

This page exists because a medical practice has to defend the choice in a partner meeting, not because the two products are interchangeable. We scored them on six operational questions: who the vendor actually sells to, how a visit is documented, how a slot is filled and confirmed, how a claim leaves the building, what certified health IT and information exchange you can verify, and what a switch does to staff time during the first month.

We opened the current product pages for both vendors and treated marketing adjectives as non-evidence. A capability counts only if the vendor describes it as a named workflow (charting, scheduling, claims, portal, e-prescribing, immunization reporting, population health). A commercial term that is not on a dated public page is written not published. That is why you will not see a dollar figure, a seat rate, or a “go-live in N weeks” claim next to either name.

The buying climate is not a greenfield EHR race. 91% of office-based physicians used a certified EHR in 2024, so most practices are replacing a live chart, not digitizing a paper closet. according to ONC, 91% of office-based physicians had adopted a certified EHR as of 2024, and more than 99% of non-federal acute care hospitals had done the same.

according to ONC, 95% of U.S. office-based physicians had adopted any EHR as of 2024, which means the conversion problem is almost always “old electronic chart to new electronic chart,” including PDFs, media, and half-mapped problem lists.

Source: ONC, National Trends in Hospital and Physician Adoption of Electronic Health Records, last updated June 2026. Hospital figures for 2020–2024 are certified EHR; physician figures for 2016–2024 are certified EHR.

Certified health IT is also the floor for federal quality programs. according to CMS, the Medicaid Promoting Interoperability Program ended on December 31, 2021, and eligible hospitals still submit Promoting Interoperability measure data on electronic prescribing, health information exchange, provider-to-patient exchange, public health and clinical data exchange, and protecting patient health information.

Source: CMS, Promoting Interoperability Programs page, last modified November 24, 2025.

We also scored both products on whether prior authorization and missed visits stay inside the EHR or leak onto phones and payer portals. according to the American Medical Association, 78% of physicians reported that prior authorization often or sometimes results in patients abandoning a recommended course of treatment.

78% of physicians saw patients abandon treatment after prior auth. according to the AMA, physicians complete an average of 43 prior authorizations per physician per week, and that work consumes 12 hours of physician and staff time each week.

Source: American Medical Association prior authorization survey, reported June–July 2024.

44% of medical groups reported slower prior auth in 2026. according to MGMA, 44% of medical group leaders said payer prior authorization turnaround became slower in 2026 compared with 2025, in a September 1, 2026 poll with 178 applicable responses.

That is the operational bar. An EHR that cannot keep eligibility, the authorization packet, and the claim attached to the same visit will spend 2026 recreating the fax pile the vendor promised to retire. US Tech Automations maps that intake-to-claim path the same way we scored these two products: named steps, named owners, no invented prices.

Who Drchrono is actually for

Drchrono (branded DrChrono by EverHealth on the vendor site) sells an all-in-one cloud EHR to independent practices. The homepage pitch is not a hospital command center. It is one platform for scheduling, documentation, and billing, used from a phone, tablet, or desktop, for clinics that range from a single provider to multi-location independent groups.

The clinical side is built around faster charting rather than a published population-health suite. The vendor lists speech-to-text, custom macros, specialty templates, forms, document management and faxing, and an in-workflow AI documentation assistant. Labs post back to the chart. State immunization registries are a named connection. Electronic prescribing includes interaction checks and Electronic Prescribing for Controlled Substances. Record locator and exchange is described as a way to pull prior records without a separate chart chase.

The front office side is the other half of the same database. Real-time appointment scheduling, automated reminders and check-ins, insurance eligibility verification, customizable calendars, and task automation sit next to an AI-assisted no-show predictor. That matters in 2026 because missed visits are not a side metric. A practice that still confirms appointments from a personal cell phone will not get the value of a cloud schedule, regardless of which logo is on the login screen.

Billing is in-product, not a promised phase two. Drchrono describes end-to-end claims, denial workflows, real-time reporting, automated payment collection, an integrated payments processor, and a proprietary clearinghouse. Patient-facing tools include a HIPAA-compliant portal, digital intake and e-signatures, online payments, telehealth with screen sharing, and visit summaries. Electronic prior authorization is submitted from inside the prescribing workflow, which is the right place for it if your PA volume is medication-heavy.

This is the buyer: an independent medical practice whose partners still see patients, whose biller sits down the hall, and whose definition of “enterprise” is a second location rather than a CIN. If your daily pain is iPad charting, eligibility at check-in, and a claim that should have gone out before the patient reached the parking lot, Drchrono is the product that is actually built around that day.

It is not the buyer if you need a documented population-health layer, a virtual front door with call deflection, or a practice-management build that a multi-specialty board will recognize as an operating system. Those gaps are not insults. They are the difference between an independent-practice EHR and a specialty-group platform.

Who NextGen is actually for

NextGen sells cloud EHR and practice management to specialty practices. The vendor’s own frame is a closed loop across access, intake, the visit, care coordination, and ongoing health management — EHR, practice management, patient experience, and revenue cycle as one story rather than four contracts.

On the clinical side, NextGen markets customizable EHR and practice-management workflows, ambient listening that turns a visit conversation into structured SOAP notes, virtual visits, mobile documentation, and e-prescribing. Specialty content is a first-class claim: the vendor says it configures to specialty realities rather than asking every clinic to invent templates from a blank note. Population health is a named module, with risk stratification, gap identification, and outreach, which is the language of groups that hold contracts rather than only fee-for-service schedules.

On the access side, NextGen describes a virtual front door: self-scheduling, reminders, recall, automated wait-list, reputation tools, and inbound call deflection. Intake includes secure messaging, pre-visit forms, document upload, cost and payment transparency, and interoperability with payers, health information exchanges, and state reporting. After the visit, the same loop covers surveys, referrals, refill traffic, statements, and portal bill pay. Remote patient monitoring is listed as an ongoing-management tool, not a footnote.

Revenue cycle is inside that loop, not a bolt-on you “might add later.” NextGen publishes a mid-to-enterprise RCM story and a small-practice track. Implementation is described as a staffed methodology: project managers, consultants, trainers, technical personnel, go-live support, and post-implementation follow-up. The vendor even says EHR replacement is challenging, which is the honest sentence a partner should hear before anyone signs.

This is the buyer: a specialty group, or a growing independent practice that already behaves like one, where referrals, payer mix, and patient access are board-level metrics. If your administrator thinks in templates, call abandonment, and denial queues as one system, NextGen is the product that is actually built around that week.

It is not the buyer if you wanted a lightweight mobile chart for a two-provider clinic and you do not intend to implement practice management, patient-access, and RCM as a project. A smaller group can still use NextGen — the vendor publishes a small-practice path — but you should walk into the quote ready to name which pieces of the loop you are actually buying.

Comparison table

The only fair table is the one you can source. Commercial cells that are not on a public, dated vendor page read not published. Feature cells reflect what the vendor describes on the pages we opened, not a lab ranking and not a user census.

Source: vendor product pages opened for this article (Drchrono, Drchrono EHR, NextGen, NextGen EHR). Commercial terms: not published.

Read the table as a workflow test, not a feature checklist. If your partners live in the exam room and the claim must leave the same database that held the note, Drchrono’s in-product billing is the load-bearing row. If your partners live in referrals, access, and contract performance, NextGen’s closed loop is the load-bearing row. A demo that only shows a pretty note template is not a comparison.

Pros and cons

Drchrono

Pros. One cloud database for the appointment, the note, and the claim is the operational win for an independent practice. Mobile-first charting matches clinics that actually document on a tablet in the room. Eligibility, reminders, and check-in sit on the same calendar the provider sees. Claims, denials, payments, and a clearinghouse are described as native, which is what you want if you are not staffing a separate RCM vendor on day one. Electronic prior authorization from inside prescribing is a real workflow, not a slide. Labs, immunization registries, e-prescribing with EPCS, and record exchange are named, which is the minimum set a 2026 certified-EHR buyer should demand.

Cons. Population health is not a named module on the pages we opened, so groups that manage gaps-in-care lists and risk contracts will be buying a chart, not a population platform. Implementation method and commercial terms are not published, so a partner cannot sanity-check total cost without a quote. Specialty depth depends on templates and macros you will have to own. Prior authorization volume still belongs to the practice: an in-workflow ePA button does not delete the 43-per-week industry load the AMA documented. If you later need a full practice-management and patient-access loop, you will be asking this EHR to grow into a job it does not advertise.

NextGen

Pros. The closed-loop story matches how a specialty group actually runs: access, intake, visit, coordination, billing. Ambient documentation and a mobile EHR are aimed at the after-hours note pile that burns out providers. Population health is named, which is the difference between an EHR and a tool a quality committee can use. Patient access is treated as a product (self-scheduling, wait-list, reminders, call deflection), not a portal afterthought. Revenue cycle is in the same conversation as the chart. Implementation is described as a staffed project, which is what a multi-site cutover actually is. A small-practice track exists, so you are not automatically in an enterprise-only funnel.

Cons. The loop is a larger buying surface. You will spend the quote meeting naming modules, interfaces, and which sites go first, because “the EHR” is not the whole product. Public list price and implementation fees are not published. The vendor itself calls replacement challenging, and a staffed methodology is both a benefit and a sign that this is not a weekend cutover. Electronic prior authorization as a named in-EHR module was not on the pages we opened, so PA work may still live in payer portals unless the quote proves otherwise. A two-provider independent clinic that only wanted mobile charting can over-buy here if nobody on the buying committee is allowed to say no to extra modules.

What switching actually costs

Neither vendor publishes a 2026 list price, an implementation fee, or a conversion calendar, so this section is a work plan, not a fake invoice. Ask both for a written quote that names seats by role, modules in scope, interfaces, training, and the dual-charting window. The number you get back will move with those inputs. Do not let a salesperson replace that list with a single monthly figure.

Data is the first cost. You are moving a certified chart, not a filing cabinet. Demand a documented extract of demographics, problems, allergies, medications, immunizations, notes, orders, results, media, and open encounters. Decide what arrives as discrete data versus PDF. The leftover paper and faxed packets are the part that blows the timeline: that is the step where US Tech Automations can run extraction so old files become fields instead of an unsearchable document tab.

Interfaces are the second cost. Labs, immunization registries, e-prescribing identity proofing, clearinghouse enrollment, eligibility, and any health information exchange feed have to be rebuilt, tested, and frozen. A “we will connect that later” line in a statement of work is how you end up printing lab results during week two. Put every interface on the quote as a dated milestone, including who owns the payer enrollment.

Retraining is the third cost. Front desk, medical assistants, providers, and billers do not learn the same screens. Budget role-based training and a named super-user per site. NextGen describes trainers and post-go-live follow-up; Drchrono does not publish that method on the pages we opened. Either way, the practice still pays in lost visits while people hunt for the charge button.

The month of cutover is the fourth cost, and it is a calendar, not a slogan. You will run dual charting or a hard cut. You will re-enroll patients on a new portal. You will see no-shows move if reminders change. 32% of medical groups reported higher no-show rates in 2026 in a separate access poll, so do not treat reminder cutover as cosmetic. according to HHS OCR, OCR settled or imposed a civil money penalty in 152 cases totaling $144,878,972.00 as of October 31, 2024, which is why access provisioning, business-associate paperwork, and audit logs belong on the conversion checklist next to the template build.

Source: workstream list is the conversion scope a practice should put on both quotes. Dollar and day counts: not published by either vendor on the pages opened.

Source: HHS OCR Enforcement Highlights, current as of October 31, 2024.

Claims work after the EHR is a separate operational layer. If your denial queue is the reason you are shopping, read Waystar AltitudeAI: What It Changes? as a revenue-cycle workflow brief, not as a third EHR on this page. If ambient documentation and “AI in the exam room” are the reason the board is restless, read Implementation Opinions on AI Agents Explained before you treat a scribe demo as an implementation plan.

The verdict

These two products are not close if you are honest about the practice you actually run. Drchrono is the independent-practice EHR: mobile charting, in-product claims, eligibility at the front desk, and electronic prior authorization from the prescription screen. NextGen is the specialty-group platform: EHR plus practice management plus patient access plus revenue cycle, with population health on the larger side and a staffed conversion.

Choose Drchrono when the partners still room their own patients, the biller is in-house, and the failure mode you fear is a note that never becomes a clean claim. Choose NextGen when the failure mode you fear is a referral that vanishes, a call queue that cannot self-schedule, or a quality contract you cannot see inside the chart. If your committee wants both a lightweight iPad chart and an enterprise access loop, you do not have a software problem yet. You have an unresolved operating model.

Who should pick the other one. A two- to four-provider independent clinic should not buy NextGen’s full loop just because a consultant said “you will grow into it.” A multi-site specialty group should not pick Drchrono just because the tablet demo was faster. Sliding-fee and FQHC reporting is a different buying problem than this head-to-head; use athenahealth vs CureMD for FQHC Sliding-Fee Data, 2026 for that workflow, not as a third option here.

Print two quotes with the same scope, walk the same patient from self-scheduling (or the front desk) through the note and the claim, and take that packet to the partner meeting. If you want the surrounding automation steps priced the same way, use the US Tech Automations pricing page and the agentic workflows overview after you have named the EHR, not before.

FAQs

Which product fits a small independent medical practice in 2026?

Drchrono is the closer fit for an independent clinic that wants scheduling, charting, and billing in one mobile cloud system. NextGen still publishes a small-practice track, so it is not off-limits, but you should walk into that quote ready to decline modules you will not implement in the first year.

Does NextGen make more sense for a multi-site specialty group?

Yes, when the group actually needs practice management, patient access, referrals, population health, and revenue cycle as one loop. If the specialty group only wanted a faster note and in-house claims, Drchrono can still be the shorter project — the specialty label alone is not a reason to buy the larger platform.

Can anyone publish a reliable 2026 price for Drchrono or NextGen?

No public 2026 list price was available for either vendor on the pages opened for this article. Ask both for a written quote that names seats by role, modules, interfaces, training, and migration, and treat any verbal monthly number as incomplete until those lines are on paper.

What should the quote include besides user count?

Include chart-conversion depth, lab and public-health interfaces, e-prescribing and EPCS enrollment, clearinghouse and eligibility, portal cutover, role-based training, the dual-charting window, and which sites go live first. Those items move the number more than the logo on the login screen.

How do you keep prior authorization from exploding the first month?

Keep eligibility, the authorization packet, and the claim attached to the same visit, and measure turnaround by payer, not by vendor anecdote. Drchrono names electronic prior authorization inside prescribing; NextGen did not publish a named in-EHR ePA module on the pages we opened, so make that a live demo with your real payers.

Should we treat AI documentation as the deciding feature?

No. Both vendors market in-workflow AI documentation, and a scribe that does not write to the correct discrete fields will still leave the biller hunting. Decide who signs the note, where the ICD suggestion lands, and how you will measure after-hours charting before you let a demo set the agenda.

When is HIPAA the conversion risk rather than a policy binder?

When you are copying charts, standing up a new portal, and issuing hundreds of new logins in the same week. Put access reviews, business-associate paperwork, and audit-log ownership on the project plan; OCR’s published enforcement totals are large enough that “we will lock that down later” is not a partner-ready sentence.

Key Takeaways

• Drchrono fits independent medical practices that want the appointment, the note, and the claim in one mobile cloud database.

• NextGen fits specialty groups that need EHR, practice management, patient access, population health, and revenue cycle as one loop.

• Neither vendor published a 2026 list price; demand a quote on seats, modules, interfaces, training, and migration.

• 91% of office-based physicians used a certified EHR in 2024, so you are converting a live chart, not a paper closet.

• Prior authorization still burns staff time across the industry; keep it inside the visit workflow or it will leak to payer portals.

• Verify each product’s current CHPL listing for the modules you will actually run, including e-prescribing and information exchange.

• Price the conversion calendar (dual charting, portal re-enrollment, interface freeze) before you compare monthly software lines.

• Map intake-to-claim once, then take both quotes and the US Tech Automations workflow view into the partner meeting.